Market Overview:
The global aerosols budesonide market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of respiratory diseases, rising awareness about the benefits of using aerosols budesonide for treating respiratory diseases, and growing demand for nose disease treatment. However, factors such as high cost and lack of reimbursement are restraining the growth of this market. Based on type, the global aerosols budesonide market can be segmented into 0.5mg and 1mg segments.
Product Definition:
Aerosols budesonide is a corticosteroid used in the treatment of asthma, allergic rhinitis, and other inflammatory conditions. It is available as an inhaler, nasal spray, or eye drop.
0.5mg:
Budesonide 0.5 mg is a type of drug known as nasal corticosteroid which is used to treat inflammation and itching of the nose, eyes, and ear canal. The medicine works by decreasing the production of cytokines (substances that trigger an immune response) in the body which reduces swelling, redness and itching.
1mg:
1mg is a white crystalline and odorless powder which is used as an active ingredient in various products such as nasal sprays, creams & ointments. It belongs to the group of medications called corticosteroids. The medicine works by decreasing inflammation all over the body including joints, skin, and digestive system. Inflammation is caused when there are some problems with the immune system or if a person has an infection like chickenpox or measles.
Application Insights:
The inflammatory bowel disease treatment segment dominated the global aerosols budesonide market in terms of revenue share in 2017. The high prevalence of IBD, increasing healthcare awareness and availability of effective treatments are some factors contributing to the segment growth.
Budesonide is used for treating respiratory diseases such as asthma and allergic rhinitis due to its anti-inflammatory property. It reduces nasal congestion, wheezing, breathlessness and itching caused by these disorders. Budesonide 0.5mg/spray is available OTC for the treatment of asthma under brand name Qutenza; while 1mg/vial is available under LUNESTAFE brand name globally. However, resumption of manufacturing activities by companies like Pfizer Inc., which was previously halted for about a year due to tax haven controversy will positively impact product demand from 2018 onward till 2030 period owing to increase in sales volume outside U.S.
Regional Analysis:
North America dominated the global aerosols budesonide market and accounted for over 39% of the total revenue share in 2017. The presence of key manufacturers coupled with high consumer awareness levels regarding rhinitis, asthma, and other respiratory diseases are some factors responsible for its large share. In addition, increasing prevalence of nasal polyps is anticipated to drive regional growth over the forecast period.
Asia Pacific is expected to be one of the fastest-growing regions owing to rapidly improving healthcare infrastructure in emerging countries such as China and India along with growing consumer awareness about available treatment options for common respiratory disorders such as asthma and rhinitis. Moreover, rising incidence rates of allergic conditions are also expected to fuel product demand during the forecast period.
Growth Factors:
- Increasing prevalence of respiratory diseases: The increasing prevalence of respiratory diseases, such as asthma, chronic obstructive pulmonary disease (COPD), and bronchitis is expected to drive the demand for aerosols budesonide in the coming years.
- Growing awareness about the benefits of using aerosols budesonide: There is a growing awareness among people about the benefits of using aerosols budesonide for treating respiratory diseases. This is likely to boost demand for these products in the near future.
- Technological advancements in manufacturing process: The technological advancements in manufacturing process are expected to result in improved quality and efficiency of aerosols budesonide products, thereby driving their demand over the forecast period.
- Rising number of product launches: The number of product launches by various players is anticipated to rise over the next few years, which will subsequently fuel growth prospects for this market during the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Aerosols Budesonide Market Research Report
By Type
0.5mg, 1mg
By Application
Respiratory Disease Treatment, Nose Disease Treatment, Inflammatory Bowel Disease Treatment, Other
By Companies
AstraZeneca, Teva, Mylan, Sandoz, Cosmo Pharmaceuticals, Salix, Chiesi Farmaceutici, Orion Corporation, Cipla, Synmosa Biopharma, AstraZeneca, Shanghai Sine Promod
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
230
Number of Tables & Figures
161
Customization Available
Yes, the report can be customized as per your need.
Global Aerosols Budesonide Market Report Segments:
The global Aerosols Budesonide market is segmented on the basis of:
Types
0.5mg, 1mg
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Respiratory Disease Treatment, Nose Disease Treatment, Inflammatory Bowel Disease Treatment, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AstraZeneca
- Teva
- Mylan
- Sandoz
- Cosmo Pharmaceuticals
- Salix
- Chiesi Farmaceutici
- Orion Corporation
- Cipla
- Synmosa Biopharma
- AstraZeneca
- Shanghai Sine Promod
Highlights of The Aerosols Budesonide Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 0.5mg
- 1mg
- By Application:
- Respiratory Disease Treatment
- Nose Disease Treatment
- Inflammatory Bowel Disease Treatment
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Aerosols Budesonide Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Aerosols Budesonide is a medication used to treat asthma. It works by reducing the amount of air that your lungs can breathe.
Some of the major companies in the aerosols budesonide market are AstraZeneca, Teva, Mylan, Sandoz, Cosmo Pharmaceuticals, Salix, Chiesi Farmaceutici, Orion Corporation, Cipla, Synmosa Biopharma, AstraZeneca, Shanghai Sine Promod.
The aerosols budesonide market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Aerosols Budesonide Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Aerosols Budesonide Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Aerosols Budesonide Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Aerosols Budesonide Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Aerosols Budesonide Market Size & Forecast, 2018-2028
4.5.1 Aerosols Budesonide Market Size and Y-o-Y Growth
4.5.2 Aerosols Budesonide Market Absolute $ Opportunity
Chapter 5 Global Aerosols Budesonide Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Aerosols Budesonide Market Size Forecast by Type
5.2.1 0.5mg
5.2.2 1mg
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Aerosols Budesonide Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Aerosols Budesonide Market Size Forecast by Applications
6.2.1 Respiratory Disease Treatment
6.2.2 Nose Disease Treatment
6.2.3 Inflammatory Bowel Disease Treatment
6.2.4 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Aerosols Budesonide Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Aerosols Budesonide Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Aerosols Budesonide Analysis and Forecast
9.1 Introduction
9.2 North America Aerosols Budesonide Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Aerosols Budesonide Market Size Forecast by Type
9.6.1 0.5mg
9.6.2 1mg
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Aerosols Budesonide Market Size Forecast by Applications
9.10.1 Respiratory Disease Treatment
9.10.2 Nose Disease Treatment
9.10.3 Inflammatory Bowel Disease Treatment
9.10.4 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Aerosols Budesonide Analysis and Forecast
10.1 Introduction
10.2 Europe Aerosols Budesonide Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Aerosols Budesonide Market Size Forecast by Type
10.6.1 0.5mg
10.6.2 1mg
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Aerosols Budesonide Market Size Forecast by Applications
10.10.1 Respiratory Disease Treatment
10.10.2 Nose Disease Treatment
10.10.3 Inflammatory Bowel Disease Treatment
10.10.4 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Aerosols Budesonide Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Aerosols Budesonide Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Aerosols Budesonide Market Size Forecast by Type
11.6.1 0.5mg
11.6.2 1mg
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Aerosols Budesonide Market Size Forecast by Applications
11.10.1 Respiratory Disease Treatment
11.10.2 Nose Disease Treatment
11.10.3 Inflammatory Bowel Disease Treatment
11.10.4 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Aerosols Budesonide Analysis and Forecast
12.1 Introduction
12.2 Latin America Aerosols Budesonide Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Aerosols Budesonide Market Size Forecast by Type
12.6.1 0.5mg
12.6.2 1mg
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Aerosols Budesonide Market Size Forecast by Applications
12.10.1 Respiratory Disease Treatment
12.10.2 Nose Disease Treatment
12.10.3 Inflammatory Bowel Disease Treatment
12.10.4 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Aerosols Budesonide Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Aerosols Budesonide Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Aerosols Budesonide Market Size Forecast by Type
13.6.1 0.5mg
13.6.2 1mg
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Aerosols Budesonide Market Size Forecast by Applications
13.10.1 Respiratory Disease Treatment
13.10.2 Nose Disease Treatment
13.10.3 Inflammatory Bowel Disease Treatment
13.10.4 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Aerosols Budesonide Market: Competitive Dashboard
14.2 Global Aerosols Budesonide Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 AstraZeneca
14.3.2 Teva
14.3.3 Mylan
14.3.4 Sandoz
14.3.5 Cosmo Pharmaceuticals
14.3.6 Salix
14.3.7 Chiesi Farmaceutici
14.3.8 Orion Corporation
14.3.9 Cipla
14.3.10 Synmosa Biopharma
14.3.11 AstraZeneca
14.3.12 Shanghai Sine Promod
